Syndax Pharmaceuticals, Inc. (SNDX) Operating income 2016–2025
Syndax Pharmaceuticals, Inc. (SNDX) annual operating income history from SEC filings — each fiscal year as reported.
-$273.1MFY2025 · since FY2016: -$43.8M → -$273.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$273.1M | +19.6% |
| FY2024 | -$339.7M | -47.7% |
| FY2023 | -$230.0M | -51.5% |
| FY2022 | -$151.8M | -678.8% |
| FY2021 | $26.2M | +136.7% |
| FY2020 | -$71.4M | -24.1% |
| FY2019 | -$57.5M | +24.2% |
| FY2018 | -$75.9M | -22.5% |
| FY2017 | -$62.0M | -41.6% |
| FY2016 | -$43.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice